Nobel Prize in medicine awarded to US duo Victor Ambros, Gary Ruvkun for discovery of microRNA
- The Nobel Prize in Medicine was awarded to Americans Victor Ambros and Gary Ruvkun for their discovery of microRNA, which regulates gene activity.
- The Nobel Assembly stated that this discovery is critically important for understanding how organisms develop and function.
- Ambros and Ruvkun conducted their research at Harvard University and Massachusetts General Hospital, respectively, according to Thomas Perlmann.
245 Articles
245 Articles
Nobel Prize for Medicine Goes to US Duo Who Discovered MicroRNA
STOCKHOLM—U.S. scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Medicine on Monday for the discovery of microRNA and its crucial role in how multicellular organisms grow and live. Their work helped explain how cells specialise and develop into different types, such as muscle and nerve cells, even though all the cells in an individual contain the same set of genes and instructions for growing and staying alive. “The Nobel’s, y…
Top 10 world news: One year of Gaza war; Victor Ambros, Gary Ruvkun awarded Nobel Prize in medicine, and more
On Monday (Oct 7), Israel marked the first anniversary of the Gaza war. The war in Gaza was triggered when Palestinian Hamas militants attacked southern Israel (on October 7 last year), killing 1,200 people and taking about 250 as hostages, according to Israeli tallies. More than 100 hostages remain held by Hamas. In other news, Victor Ambros and Gary Ruvkun have been awarded the Nobel Prize in physiology or medicine 2024 for their work on micro…
Nobel prize for medicine goes to U.S. duo who discovered microRNA | Honolulu Star-Advertiser
STOCKHOLM >> U.S. scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Medicine on Monday for the discovery of microRNA and its crucial role in how multicellular organisms grow and live.
Coverage Details
Bias Distribution
- 56% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage